Navigation Links
BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
Date:4/5/2011

an "enriched" enrollment, double-blind, placebo-controlled, randomized withdrawal study measuring the efficacy and safety of BEMA Buprenorphine in patients with moderate to severe chronic pain.  Patients meeting the designated study criteria undergo titration with BEMA Buprenorphine to a dose that is both effective and well-tolerated.  Those patients who identify an effective and well tolerated dose are then randomized to either continue their BEMA Buprenorphine dose or begin use of a placebo (BEMA film with no active drug) for twelve weeks.  The primary efficacy measure is the mean change in pain intensity from the time patients are randomized (to BEMA Buprenorphine or placebo) through to the end of the twelve week study period.  The study design described has been utilized for a number of the opioid analgesics approved by the FDA in recent years.  The study design includes an interim analysis to confirm the number of patients needed for adequate statistical power.  This interim analysis is part of the study design agreed upon with FDA and is included solely to provide assurance that the sample size is adequate to detect the effect difference between the active and placebo treatments. 

About BioDelivery Sciences International

BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics.  BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and oncology supportive care.  BDSI's pain franchise currently consists of two products utilizing the patented BEMA technology.  ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada,
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
2. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
3. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
4. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
5. TCG Lifesciences Expands Pharmaceutical, Biotechnology Research Initiatives with CAS SciFinder®
6. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
7. Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
8. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
9. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
10. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
11. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... HILL, N.C. , March 27, 2015  The ... intimidating job description: ensure products meet quality standards at ... budgets and escalating regulations, quality leaders also have the ... and risk. Those who don,t effectively balance ... function as well as marketplace failure and regulatory scrutiny. ...
(Date:3/27/2015)... -- Dynatronics Corporation (NASDAQ: DYNT ) today announced that ... Company,s Board of Directors effective March 23, 2015, to fill ... board member Joseph Barton .  "The ... Directors represents an important step forward for the company," said ... "Rich is a proven leader and is well-known for his ...
(Date:3/27/2015)... -- The Temple Health & Bioscience District (THBD) today announced ... 1802 South First St. in the Temple Medical and Education ... City of Temple to receive funding for redevelopment. ... Veterans Health Care System, the new facility will enable THBD ... and life science companies. Temple ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2
... 26 Healthy Advice ® Networks, the ... consumers and physicians, is pleased to announce they ... award-winning consumer health information once again by the ... such renowned institutions as the Mayo Clinic and ...
... Medco Health Solutions, Inc. (NYSE: MHS ) ... to help protect themselves against certain unnecessary health risks.  The ... of gaps in care that could harm their health and ... was announced today at Medco,s Best Practices Workshop, an annual ...
Cached Medicine Technology:Healthy Advice® Networks Wins 39 National Health Information Awards 2Healthy Advice® Networks Wins 39 National Health Information Awards 3Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks 2Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks 3Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks 4
(Date:3/29/2015)... Youth Villages will participate in a partnership with ... feasibility of implementing a Pay for Success model to ... families. , Third Sector Capital Partners Inc. ran a ... technical assistance throughout 2015 toward a Pay for Success ... chosen by Third Sector. The organization’s work with the ...
(Date:3/29/2015)... North American Seminars receives Texas Board ... Education Courses . , Utilizing Pilates to ... TPTA, approval # 56399TX      , The Interactive ... complex - 10.5 hours - Texas Board of Physical ... Treatment of the SI Joint - 10 hours - ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of ... of their new natural sunscreen. They are offering the ... Both options come with a bonus lip balm sunscreen. , ... Amazon. Click to see the natural sunscreen on ... sunscreen is made with non-nano zinc oxide and provides broad-based ...
(Date:3/28/2015)... March 28, 2015 Could genetic code ... new study by researchers at the Harvard ... with the support of the Coffee and Caffeine Genetics ... Psychiatry this past fall, the study—one of several recent ... genomic data from more than 120,000 regular coffee drinkers ...
(Date:3/28/2015)... 2015 Take a bite of warm, ... action. Acids tumble into the stomach, ready to break ... structure lets these acids run amok, triggering a burning ... symptom. More than 60 million Americans have heartburn at ... heartburn starts, and how it can be stopped. , ...
Breaking Medicine News(10 mins):Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2
... Jerusalem, Nov. 9, 2009 Research carried out among thousands ... a loss of bone mass, leading to osteoporosis and fractures. ... researchers, Prof. Raz Yirmiya, head of the Brain and Behavior ... They further revealed that the relationship between depression and bone ...
... SAN DIEGO, Nov. 9 Renewal Laboratories announced today ... produce functional beverages with important anti-oxidants and omega3 fatty ... Q10, resveratrol, and omega3 fish oil may now be ... company will soon premier a unique line of all ...
... Doctor house calls now ... ... pain management physician, will now offer routine house calls to residents of Manhattan in New York ... at 212-918-1629 or sending an email from davisbregman.com . The convenience of being able to ...
... ... both CAMTS and EURAMI accreditation and Department of Defense approval, , ... Birmingham, AL (PRWEB) November 9, 2009 ... full accreditation from the European Aero-Medical Institute (EURAMI). EURAMI is a Stuttgart, Germany, ...
... Bregman , a pain management physician will now offer routine house ... be able to request a house call by ... davisbregman.com . The convenience of being able to see the ... this new way of seeing most patients. The service will be ...
... O,Brien, president of Catholics for Choice, issued the following statement ... recent weeks tells us and the American voters a lot ... to our core values, seeking to overcome the struggles ordinary ... cannot afford basic healthcare or have to choose between maintaining ...
Cached Medicine News:Health News:Connection between depression and osteoporosis detailed by Hebrew University researchers 2Health News:Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
Medicine Products: